Education Gap To decrease rates of bronchopulmonary dysplasia among extremely preterm infants, clinicians must implement multiple evidence-based strategies that target disease prevention. Less invasive surfactant administration is an emerging therapy that may help prevent bronchopulmonary dysplasia.